The shareholders of IMU might want to look into the person that has just been appointed head of the FDA regulatory agency (CBER) that will be responsible for approving Azer Cel. There is a rational reason the entire cell and gene therapy biotech sector fell like a stone overnight.
https://edition.cnn.com/2025/05/06/health/fda-vinay-prasad-vaccines
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.010(3.64%) |
Mkt cap ! $76.45M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.0¢ | $429.4K | 1.618M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 433247 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 28052 | 5 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| IMU (ASX) Chart |